Saudi Kayan Petrochemical Co. widened 2025 net loss to SAR 2.29 billion, from SAR 1.8 billion a year earlier.
| Item | 2024 | 2025 | Change |
|---|---|---|---|
| Revenues | 8,726.03 | 8,458.85 | (3.1 %) |
| Gross Income | (642.46) | (893.86) | (39.1 %) |
| Operating Income | (1133.73) | (1643.11) | (44.9 %) |
| Net Income | (1803.72) | (2293.88) | (27.2 %) |
| Average Shares | 1,500.00 | 1,500.00 | - |
| Earnings Per Share before unusual items (Riyals) | (1.38) | (1.58) | (14.7 %) |
| EPS (Riyal) | (1.20) | (1.53) | (27.2 %) |
The company said revenues dropped, compared to 2024 due to a decline in average selling prices, despite improved operational efficiency due to higher sales volumes and better plant reliability.
| Item | Q4 2024 | Q4 2025 | Change |
|---|---|---|---|
| Revenues | 2,245.31 | 2,012.96 | (10.3 %) |
| Gross Income | (396.77) | (304.74) | 23.2 % |
| Operating Income | (522.59) | (525.36) | (0.5 %) |
| Net Income | (685.61) | (685.49) | 0.0 % |
| Average Shares | 1,500.00 | 1,500.00 | - |
| Earnings Per Share before unusual items (Riyal) | (0.50) | (0.46) | 9.4 % |
| EPS (Riyal) | (0.46) | (0.46) | 0.0 % |
| Item | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Revenues | 2,152.81 | 2,012.96 | (6.5 %) |
| Gross Income | (88.08) | (304.74) | (246.0 %) |
| Operating Income | (278.21) | (525.36) | (88.8 %) |
| Net Income | (336.25) | (685.49) | (103.9 %) |
| Average Shares | 1,500.00 | 1,500.00 | - |
| Earnings Per Share before unusual items (Riyal) | (0.30) | (0.46) | (54.7 %) |
| EPS (Riyal) | (0.22) | (0.46) | (103.9 %) |
Q4 2025 net loss stood at SAR 685.5 million, compared to SAR 685.6 million in the prior-year period.
On a sequential basis, Saudi Kayan deepened losses from SAR 336.2 million in Q3 2025.
Total shareholders’ equity (no minority interest) amounted to SAR 9.19 billion as of Dec. 31, 2025, compared to SAR 11.5 billion in a year earlier period.
Accumulated losses reached SAR 6.52 billion by Dec. 31, 2025, accounting for 43.47% of capital.
Attached Documents
| Company | Estimated | Actual | Change |
|---|---|---|---|
| SAUDI KAYAN | (496.50) | (685.49) | |
| LUMI | 48.32 | 38.02 | |
| SAUDI GERMAN HEALTH | 57.43 | 37.79 | |
| MARAFIQ | 54.00 | 51.22 | |
| JAMJOOM PHARMA | 72.76 | 68.07 | |
| SSP | 25.90 | 44.66 | |
| SHAKER | 16.30 | 16.83 | |
| LEEJAM SPORTS | 88.58 | 78.79 | |
| CARE | 86.37 | 70.96 | |
| STC | 3,507.08 | 3,248.66 |
| Company | Estimated | Actual | Change |
|---|---|---|---|
| SAUDI KAYAN | (496.50) | (685.49) | |
| LUMI | 48.32 | 38.02 | |
| SAUDI GERMAN HEALTH | 57.43 | 37.79 | |
| MARAFIQ | 54.00 | 51.22 | |
| JAMJOOM PHARMA | 72.76 | 68.07 | |
| SSP | 25.90 | 44.66 | |
| SHAKER | 16.30 | 16.83 | |
| LEEJAM SPORTS | 88.58 | 88.39 | |
| CARE | 86.37 | 70.96 | |
| STC | 3,507.08 | 3,118.65 |
Be the first to comment
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website

Comments Analysis: